Tirzepatide

LY3298176

Tirzepatide is a synthetic peptide studied in in-vitro and preclinical research as a dual agonist of the GLP-1 and GIP receptors. Research reagent only — not for human consumption or medical use.

Key facts

Class: Dual incretin agonist
Targets: GLP-1 / GIP
Form: Lyophilised (powder)
Status: Research Use Only

Documented research areas

Incretin signallingGLP-1 / GIP agonismPreclinical models

See Tirzepatide

Study library

All results on PubMed

Dual incretin Metabolism LY3298176

The study list is temporarily unavailable.

Results retrieved live from PubMed (NCBI). Research literature only — no medical advice.

Research peptides — Research Use Only

Not for human consumption
Not for the diagnosis, treatment or prevention of any disease